Oral Health Researcher Wins PM's Innovation Prize
19th Oct 17
Laureate Professor Eric Reynolds AO from the Oral Health Cooperative Research Centre has won this year's Prime Minister’s Prize for Innovation for his work in discovering a protein that repairs and strengthens teeth, something now widely used in consumer and healthcare products.
Key Issues For The Dental Industry —
The peak business organisation representing dental product manufacturers and suppliers, the Australian Dental Industry Association (ADIA), has congratulated Laureate Professor Eric Reynolds AO for winning the Prime Minister’s Prize for Innovation.
Prof. Reynolds won the award based upon his research which discovered a protein in dairy milk that repairs and strengthens teeth. Today, that protein, sold as Recaldent, is used by millions of people every day as they chew gum and visit the dentist. For inventing and commercialising Recaldent, Professor Eric Reynolds receives the $250,000 Prime Minister’s Prize for Innovation.
ADIA is an active champion for those Australians who undertake research, development and commercialisation of dental and oral health products. This is a major focus of ADIA's work and Prof. Reynolds' prize showcases what Australian’s can accomplish.
A priority for ADIA is to support those businesses that empower healthcare professionals to advance the oral health of all Australians as a result of developing pioneering diagnostic and treatment options. Prof. Renyolds research has shown exactly how that can be achieved and he is also tackling another major oral health challenge – gum disease or peridontitis.
“Most of us will get a bit of mild gum disease or peridontitis from time to time when ‘bad’ bacteria in our mouths get out of balance with ‘good’ bacteria. Bacteria get between our gums and our teeth and an inflammation kicks off. If we’re unlucky then the peridontitis bacterium moves in, leading to bone loss and ultimately our teeth fall out. Peridontitis is also implicated in other issues from rheumatoid arthritis to oral cancer,” Prof. Reynolds said.
Businesses involved in dental product research, development and commercialisiation are encouraged to be part of the ADIA-MIG Manufacturers Interest Group, a forum that brings together businesses to develop collaborative networks to further their manufacturing and export goals.
Member engagement —
ADIA provides leadership, strategy, advocacy and support. Our members set our agenda, fund our activities and directly benefit from the results. Businesses with an interest in the research, development, commercialisation, manufacture and export of dental products convene under the umbrella of the ADIA-MIG Manufacturers Interest Group.
Currency & Disclaimer —
This update was issued on 19 October 2017 and please note that changes in circumstances after the publication of material or information may impact upon its accuracy and also change regulatory compliance obligations. The statements, regulatory and technical information contained herein are believed to be accurate and are provided for information purposes only. Readers are responsible for assessing its relevance and verifying the accuracy of the content. To the fullest extent permitted by law, ADIA will not be liable for any loss, damage, cost or expense incurred in relation to or arising as a result of relying on the information presented here.
This publication is available for your use under a Creative Commons Attribution 3.0 Australia licence, with the exception of the ADIA logo, other images and where otherwise stated.
|A —.. A D I A . .S T R A T E G I C . .A L L I A N C E S
|* To access this file you will need to log into your ADIA Member Plus account.
...If you have misplaced your details email firstname.lastname@example.org or telephone 1300 943 094.
21st Apr 17
New determinations of ADIA Code of Practice complaints have confirmed it's not possible to provide healthcare professionals with gift cards. New guidance is also available on the provision of other gifts with dental product purchases.
6th Mar 19
The Therapeutic Goods Administration (TGA) has released an update on Brexit and the implications for therapeutic goods in Australia under any of the possible agreements that could occur.